Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Proponents often highlight the possibility for meaningful therapeutic gains, principally in diseases where conventional medications have proven limited. However, crucially important to evaluate the considerable financial burden associated with CPI st